Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
Study title | Condition | Phase | Location |
---|---|---|---|
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) |
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia | Phase3 | United States Germany United Arab Emirates India Malaysia Jordan Turkey Greece Italy France Slovakia Czechia Romania Hungary Argentina Korea, Republic of Netherlands Switzerland United Kingdom Canada Oman Bulgaria South Africa Singapore View All |
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients |
Sickle Cell Disease (SCD) | Phase2 | United States Turkey Spain Lebanon Germany Belgium Colombia United Kingdom Italy Oman Brazil View All |
Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France |
Multiple Sclerosis (MS) | France | |
Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). |
Fascioliasis | Phase4 | Egypt Peru Colombia Vietnam View All |
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. |
Lymphatic Malformations | Phase2, Phase3 | United States Australia France Germany Spain View All |
Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) |
Polymyalgia Rheumatica | Phase3 | United States Denmark France Netherlands Turkey Japan Lebanon Germany Spain United Kingdom Colombia Switzerland Italy Czechia Hungary Poland Argentina South Africa Mexico Australia Israel Belgium Canada Brazil Chile View All |
Special Drug Use-results Surveillance of Tafinlar/Mekinist |
BRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid Tumor | Japan | |
A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan |
Neuroendocrine Neoplasms | Phase3 | Japan |
A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids |
Primary Immune Thrombocytopenia | Phase3 | United States Turkey Japan Thailand Spain China France Italy Czechia Romania Hungary Argentina India Australia Germany Norway Korea, Republic of Malaysia Taiwan Belgium Austria United Kingdom Philippines Singapore Netherlands View All |
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. |
Chronic Spontaneous Urticaria | Phase3 | India Brazil Netherlands Korea, Republic of Turkey Germany Argentina Thailand Spain Slovakia France Czechia Canada Poland Switzerland Malaysia Hungary Australia Italy Bulgaria Taiwan View All |
Pagination
- ‹‹ Previous page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- …
- 18
- ›› Next page